Dexmedetomidine Hydrochloride

盐酸右美托咪定

Report date: 2026/05/20 20:02:01
NME

Base Information

Drug NameDexmedetomidine Hydrochloride
Drug Alias Name盐酸右美托咪啶DEX-TD右美托咪定DEX-SLDexmedetomidinum +[15] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdrenergic receptors alpha-2 agonists
TargetsAdrenergic receptors alpha-2
Therapy Area/IndicationsSedationPreoperative AnxietyAgitation +[79] 
Global Approved IndicationsSedation
Approved Indications in ChinaSedation
Original Approved Country/TerritoryUnited States
Original Approved Date1999/12/17
Country/TerritoryCanadaUnited StatesThailand +[19] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesOrion Corp
China Registration ClassN/A

Develop Information

Active CompaniesCentre Integre Universitaire De Sante Et Services Sociaux Du Nord De L'Ile De MontrealWoolcock Institute Of Medical ResearchPrince Sultan Military Medical City +[45] 
Inactive CompaniesCarelon ResearchHospiraUniversity Of California San Francisco +[36] 
Active IndicationsSedationPreoperative AnxietyAgitation +[52] 
Inactive IndicationsMental DisordersBurnsRadius Fractures +[27] 

Other Information

ATC CodeN05CM18
Related LinksWikipediaDrugBankKEGG